- FDA approves Novartis drug for high blood pressure treatment
- New cardiovascular risk calculator now available online
- Pfizer forms licensing agreement with Seattle Genetics
- Adherence among chronic disease patients can lead to big savings
- PhRMA: Nearly 300 preventive medicines for heart disease, stroke in development
BAKERSFIELD, Calif. — Walgreens was singled out in a lawsuit earlier this week here for suggesting a vitamin E supplement may help improve cardiovascular health.
Specifically, according to a Reuters report Monday, the complainant stated that Walgreens' Vitamin E 400 IU purported to "naturally contribute to cardiovascular health by helping to protect LDL cholesterol from oxidation which may cause cellular damage."
The plaintiff may have an uphill battle, however. According to the National Institute of Health's Office of Dietary Supplements, vitamin E has been shown to do exactly that.
"Evidence that vitamin E could help prevent or delay coronary heart disease comes from several sources," the government agency notes on its Dietary Supplement Fact Sheet on vitamin E for health professionals. "In vitro studies have found that the nutrient inhibits oxidation of low-density lipoprotein cholesterol, thought to be a crucial initiating step for atherosclerosis [hardening of the arteries]. Vitamin E might also help prevent the formation of blood clots that could lead to a heart attack or venous thromboembolism."
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.